By

By

Taren Grom, Editor

On The Cover

Midsize Pharma: Moving & Shaking the Industry
By Taren Grom, Editor Unlike their large pharmaceutical counterparts, midsize pharmaceutical companies are usually not constrained by huge overheads or layers of bureaucracy. What these companies do have is a more narrow business focus, which allows them to concentrate on specific areas of drug development. That, in turn, allows them to focus mostly on [...]

By

Taren Grom, Editor

Features

Bio Meets Pharma to Form the New Age of Biopharma
By Denise Myshko In the future, broad-based companies will choose the most appropriate approach, whether small molecule or biologic, to create new interventions. The distinction between biotech and pharma is blurring. The result: broad-based companies use their expertise in a disease and the underlying science to choose the most appropriate approach, whether small molecule or [...]

By

Denise Myshko

The 6th Annual PharmaLinx Charity Golf Outing
Raising More than ,000 for the Lankenau Institute for Medical Research Hosted by PharmaVoice Magazine and AXIS Healthcare Communications LLC The 6th Annual PharmaLinx Charity Golf Outing October 2006 We Extend Thanks to These Companies for Their Contributions Corporate Sponsors GOLD CORPORATE SPONSORS Gallagher Belmont, a division of Gallagher Benefit Services Inc. J. Knipper and [...]

By

Pink Ribbons of Opportunity
By Cynthia Borda Despite advances in breast cancer treatments, this is still an area of unmet need. Significant opportunities exist in this market, especially for products that are targeted and that have fewer side effects. Tremendous progress has been made in treating breast cancer. Survival rates have increased because of earlier diagnosis and new therapies, [...]

By

Cynthia Borda

Calculated Risks — Bassil Dahiyat
In a business climate in which caution and proven outcomes dominate, Bassil Dahiyat, Ph.D., is a daring and enthusiastic exception to the rule. Risk is not a word that frightens the young entrepreneur. He founded his own company, Xencor Inc., directly after completing his Ph.D., based on the protein design automation he helped develop for [...]

By

Kim Ribbink

A Market for Education
No longer is patient education a static, one-dimensional tool for disseminating health information. It is a dynamic way to engage patients that ensures a win-win for all parties. The face of patient care is changing, and with it so too must the way the industry engages with this critical audience. No longer is patient education [...]

By

Kim Ribbink

Metrics: It’s All About Performance
By Taren Grom, Editor From the clinic to the market, the ability to drive process improvement and operational excellence for sponsors and providers through strategic metrics has never been more important. Metrics encourage effectiveness, efficiencies, and appropriate levels of control. No matter what the sector or the task, metrics make it possible to measure an [...]

By

Taren Grom, Editor

Table of Contents
A.J. Kazimi says public perception is one obstacle midsize companies face. Jill Balderson says patients need more information about diseases. Dr. Dahiyat’s technology could change the face of medicine. October 2006 PharmaVOICE On the Cover Midsize pharma: Moving and shaking the industry Unlike their large pharmaceutical counterparts, midsize companies are usually not constrained by huge [...]